Morning Overview on MSN
The government just greenlit a daraxonrasib expanded-access program for pancreatic-cancer patients with the KRAS G12C mutation — opening the new target…
For the roughly 1 to 2 percent of pancreatic-cancer patients whose tumors carry a specific genetic glitch called KRAS G12C, ...
The expanded access program (EAP) is available to eligible patients with erythropoietic protoporphyria (EPP) and provides access to bitopertin ...
When COVID-19 vaccines entered the commercial market last fall, the federal government introduced a program to make shots accessible to people with limited coverage or no insurance. That program – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results